The latest study on Oral Antidiabetic (OAD) Treatment Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Oral Antidiabetic (OAD) Treatment Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Oral Antidiabetic (OAD) Treatment and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Pfizer
Eli Lilly
Merck
Sanofi
AstraZeneca
Glenmark
Novartis
Boehringer Ingelheim
Novo Nordisk
Mannkind
Oral Antidiabetic (OAD) Treatment Market Analysis By Type Segment:
Sulphonylureas
Biguanides
Intestinal -Glucosidase Inhibitors
Others
Oral Antidiabetic (OAD) Treatment Market Analysis By Application Segment:
Hospital
Clinics
Diabetics Treatment Centres
Others
Oral Antidiabetic (OAD) Treatment Market Analysis By Regions (Countries):
The Oral Antidiabetic (OAD) Treatment Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Oral Antidiabetic (OAD) Treatment Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Oral Antidiabetic (OAD) Treatment Market:
Oral Antidiabetic (OAD) Treatment market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Oral Antidiabetic (OAD) Treatment Market status and future forecast.
To present the key Oral Antidiabetic (OAD) Treatment Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type (2016-2027)
1.4.2 Sulphonylureas
1.4.3 Biguanides
1.4.4 Intestinal -Glucosidase Inhibitors
1.4.5 Others
1.5 Market by Application
1.5.1 Global Oral Antidiabetic (OAD) Treatment Market Share by Application (2016-2027)
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Diabetics Treatment Centres
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Oral Antidiabetic (OAD) Treatment Market Size
2.2 Oral Antidiabetic (OAD) Treatment Growth Trends by Regions
2.2.1 Oral Antidiabetic (OAD) Treatment Market Size by Regions (2016-2027)
2.2.2 Oral Antidiabetic (OAD) Treatment Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Oral Antidiabetic (OAD) Treatment Market Size by Manufacturers
3.1.1 Global Oral Antidiabetic (OAD) Treatment Revenue by Manufacturers (2020)
3.1.2 Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Manufacturers (2020)
3.1.3 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Oral Antidiabetic (OAD) Treatment Key Players Head office and Area Served
3.3 Key Players Oral Antidiabetic (OAD) Treatment Product/Solution/Service
3.4 Date of Enter into Oral Antidiabetic (OAD) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2020)
4.2 Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2020)
5 United States
5.1 United States Oral Antidiabetic (OAD) Treatment Market Size (2016-2020)
5.2 Oral Antidiabetic (OAD) Treatment Key Players in United States
5.3 United States Oral Antidiabetic (OAD) Treatment Market Size by Type
5.4 United States Oral Antidiabetic (OAD) Treatment Market Size by Application
6 Europe
6.1 Europe Oral Antidiabetic (OAD) Treatment Market Size (2016-2020)
6.2 Oral Antidiabetic (OAD) Treatment Key Players in Europe
6.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type
6.4 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application
7 China
7.1 China Oral Antidiabetic (OAD) Treatment Market Size (2016-2020)
7.2 Oral Antidiabetic (OAD) Treatment Key Players in China
7.3 China Oral Antidiabetic (OAD) Treatment Market Size by Type
7.4 China Oral Antidiabetic (OAD) Treatment Market Size by Application
8 Japan
8.1 Japan Oral Antidiabetic (OAD) Treatment Market Size (2016-2020)
8.2 Oral Antidiabetic (OAD) Treatment Key Players in Japan
8.3 Japan Oral Antidiabetic (OAD) Treatment Market Size by Type
8.4 Japan Oral Antidiabetic (OAD) Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size (2016-2020)
9.2 Oral Antidiabetic (OAD) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size by Type
9.4 Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size by Application
10 India
10.1 India Oral Antidiabetic (OAD) Treatment Market Size (2016-2020)
10.2 Oral Antidiabetic (OAD) Treatment Key Players in India
10.3 India Oral Antidiabetic (OAD) Treatment Market Size by Type
10.4 India Oral Antidiabetic (OAD) Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Oral Antidiabetic (OAD) Treatment Market Size (2016-2020)
11.2 Oral Antidiabetic (OAD) Treatment Key Players in Central & South America
11.3 Central & South America Oral Antidiabetic (OAD) Treatment Market Size by Type
11.4 Central & South America Oral Antidiabetic (OAD) Treatment Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oral Antidiabetic (OAD) Treatment Introduction
12.1.4 Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)
12.1.5 Pfizer Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oral Antidiabetic (OAD) Treatment Introduction
12.2.4 Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)
12.2.5 Eli Lilly Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oral Antidiabetic (OAD) Treatment Introduction
12.3.4 Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)
12.3.5 Merck Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oral Antidiabetic (OAD) Treatment Introduction
12.4.4 Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)
12.4.5 Sanofi Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oral Antidiabetic (OAD) Treatment Introduction
12.5.4 AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)
12.5.5 AstraZeneca Recent Development
12.6 Glenmark
12.6.1 Glenmark Company Details
12.6.2 Company Description and Business Overview
12.6.3 Oral Antidiabetic (OAD) Treatment Introduction
12.6.4 Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)
12.6.5 Glenmark Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Oral Antidiabetic (OAD) Treatment Introduction
12.7.4 Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)
12.7.5 Novartis Recent Development
12.8 Boehringer Ingelheim
12.8.1 Boehringer Ingelheim Company Details
12.8.2 Company Description and Business Overview
12.8.3 Oral Antidiabetic (OAD) Treatment Introduction
12.8.4 Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)
12.8.5 Boehringer Ingelheim Recent Development
12.9 Novo Nordisk
12.9.1 Novo Nordisk Company Details
12.9.2 Company Description and Business Overview
12.9.3 Oral Antidiabetic (OAD) Treatment Introduction
12.9.4 Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)
12.9.5 Novo Nordisk Recent Development
12.10 Mannkind
12.10.1 Mannkind Company Details
12.10.2 Company Description and Business Overview
12.10.3 Oral Antidiabetic (OAD) Treatment Introduction
12.10.4 Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)
12.10.5 Mannkind Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Oral Antidiabetic (OAD) Treatment Key Market Segments
Table Key Players Oral Antidiabetic (OAD) Treatment Covered
Table Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type 2016-2027
Figure Sulphonylureas Figures
Table Key Players of Sulphonylureas
Figure Biguanides Figures
Table Key Players of Biguanides
Figure Intestinal -Glucosidase Inhibitors Figures
Table Key Players of Intestinal -Glucosidase Inhibitors
Figure Others Figures
Table Key Players of Others
Table Global Oral Antidiabetic (OAD) Treatment Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospital Case Studies
Figure Clinics Case Studies
Figure Diabetics Treatment Centres Case Studies
Figure Others Case Studies
Figure Oral Antidiabetic (OAD) Treatment Report Years Considered
Table Global Oral Antidiabetic (OAD) Treatment Market Size 2016-2027 (Million US$)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Regions 2016-2027 (Million US$)
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Regions 2016-2020 (Million US$)
Table Global Oral Antidiabetic (OAD) Treatment Market Share by Regions 2016-2020
Figure Global Oral Antidiabetic (OAD) Treatment Market Share by Regions 2016-2020
Figure Global Oral Antidiabetic (OAD) Treatment Market Share by Regions 2020
Table Market Top Trends
Table Global Oral Antidiabetic (OAD) Treatment Revenue by Manufacturers (2020) (Million US$)
Table Global Oral Antidiabetic (OAD) Treatment Market Share by Manufacturers (2020)
Figure Global Oral Antidiabetic (OAD) Treatment Market Share by Manufacturers in 2020
Table Global Oral Antidiabetic (OAD) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Oral Antidiabetic (OAD) Treatment Product/Solution/Service
Table Date of Enter into Oral Antidiabetic (OAD) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2020) (Million US$)
Table Global Oral Antidiabetic (OAD) Treatment Market Size Share by Type (2016-2020)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2016-2020)
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2020) (Million US$)
Table Global Oral Antidiabetic (OAD) Treatment Market Size Share by Application (2016-2020)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2016-2020)
Figure Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Application in 2020
Figure United States Oral Antidiabetic (OAD) Treatment Market Size 2016-2020 (Million US$)
Table United States Key Players Oral Antidiabetic (OAD) Treatment Revenue (2020) (Million US$)
Table United States Key Players Oral Antidiabetic (OAD) Treatment Market Share (2020)
Table United States Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2020) (Million US$)
Table United States Oral Antidiabetic (OAD) Treatment Market Share by Type (2016-2020)
Table United States Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2020) (Million US$)
Table United States Oral Antidiabetic (OAD) Treatment Market Share by Application (2016-2020)
Figure Europe Oral Antidiabetic (OAD) Treatment Market Size 2016-2020 (Million US$)
Table Europe Key Players Oral Antidiabetic (OAD) Treatment Revenue (2020) (Million US$)
Table Europe Key Players Oral Antidiabetic (OAD) Treatment Market Share (2020)
Table Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2020) (Million US$)
Table Europe Oral Antidiabetic (OAD) Treatment Market Share by Type (2016-2020)
Table Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2020) (Million US$)
Table Europe Oral Antidiabetic (OAD) Treatment Market Share by Application (2016-2020)
Figure China Oral Antidiabetic (OAD) Treatment Market Size 2016-2020 (Million US$)
Table China Key Players Oral Antidiabetic (OAD) Treatment Revenue (2020) (Million US$)
Table China Key Players Oral Antidiabetic (OAD) Treatment Market Share (2020)
Table China Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2020) (Million US$)
Table China Oral Antidiabetic (OAD) Treatment Market Share by Type (2016-2020)
Table China Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2020) (Million US$)
Table China Oral Antidiabetic (OAD) Treatment Market Share by Application (2016-2020)
Figure Japan Oral Antidiabetic (OAD) Treatment Market Size 2016-2020 (Million US$)
Table Japan Key Players Oral Antidiabetic (OAD) Treatment Revenue (2020) (Million US$)
Table Japan Key Players Oral Antidiabetic (OAD) Treatment Market Share (2020)
Table Japan Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2020) (Million US$)
Table Japan Oral Antidiabetic (OAD) Treatment Market Share by Type (2016-2020)
Table Japan Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2020) (Million US$)
Table Japan Oral Antidiabetic (OAD) Treatment Market Share by Application (2016-2020)
Figure Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Oral Antidiabetic (OAD) Treatment Revenue (2020) (Million US$)
Table Southeast Asia Key Players Oral Antidiabetic (OAD) Treatment Market Share (2020)
Table Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Oral Antidiabetic (OAD) Treatment Market Share by Type (2016-2020)
Table Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Oral Antidiabetic (OAD) Treatment Market Share by Application (2016-2020)
Figure India Oral Antidiabetic (OAD) Treatment Market Size 2016-2020 (Million US$)
Table India Key Players Oral Antidiabetic (OAD) Treatment Revenue (2020) (Million US$)
Table India Key Players Oral Antidiabetic (OAD) Treatment Market Share (2020)
Table India Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2020) (Million US$)
Table India Oral Antidiabetic (OAD) Treatment Market Share by Type (2016-2020)
Table India Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2020) (Million US$)
Table India Oral Antidiabetic (OAD) Treatment Market Share by Application (2016-2020)
Figure Central & South America Oral Antidiabetic (OAD) Treatment Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Oral Antidiabetic (OAD) Treatment Revenue (2020) (Million US$)
Table Central & South America Key Players Oral Antidiabetic (OAD) Treatment Market Share (2020)
Table Central & South America Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2020) (Million US$)
Table Central & South America Oral Antidiabetic (OAD) Treatment Market Share by Type (2016-2020)
Table Central & South America Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2020) (Million US$)
Table Central & South America Oral Antidiabetic (OAD) Treatment Market Share by Application (2016-2020)
Table Pfizer Company Details
Table Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2020) (Million US$)
Figure Pfizer Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020)
Table Pfizer Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020)
Table Eli Lilly Recent Development
Table Merck Company Details
Table Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)(Million US$)
Figure Merck Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020)
Table Merck Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)(Million US$)
Figure Sanofi Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020)
Table Sanofi Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020)
Table AstraZeneca Recent Development
Table Glenmark Company Details
Table Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)(Million US$)
Figure Glenmark Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020)
Table Glenmark Recent Development
Table Novartis Company Details
Table Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)(Million US$)
Figure Novartis Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020)
Table Novartis Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020)
Table Boehringer Ingelheim Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020)
Table Novo Nordisk Recent Development
Table Mannkind Company Details
Table Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2020)(Million US$)
Figure Mannkind Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2020)
Table Mannkind Recent Development
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Regions (Million US$) 2021-2027
Figure Global Oral Antidiabetic (OAD) Treatment Market Size Share by Regions (2021-2027)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size Share by Regions in 2027
Figure United States Oral Antidiabetic (OAD) Treatment Market Size Forecast (2021-2027)(Million USD)
Figure Europe Oral Antidiabetic (OAD) Treatment Market Size Forecast (2021-2027)(Million USD)
Figure China Oral Antidiabetic (OAD) Treatment Market Size Forecast (2021-2027)(Million USD)
Figure Japan Oral Antidiabetic (OAD) Treatment Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size Forecast (2021-2027)(Million USD)
Figure India Oral Antidiabetic (OAD) Treatment Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Oral Antidiabetic (OAD) Treatment Market Size Forecast (2021-2027)(Million USD)
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Product (2021-2027) (Million US$)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size by Product (2021-2027)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size by Product in 2027
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2021-2027) (Million US$)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2021-2027)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources